Guidance

Medicines eligible for Northern Ireland MHRA Authorised Route

Sets out medicines that can be moved to Northern Ireland to meet patient need.

Documents

Details

This document lists the medicines eligible for supply through the Northern Ireland MHRA Authorised Route (NIMAR).

The listed medicines may be dispatched from Great Britain to Northern Ireland on the basis of the medicine’s authorisation in Great Britain.

This list is maintained and published in accordance with regulation 167B (list of NIMAR products) of the Human Medicines Regulations 2012 (SI 2012/1916, as amended).

Updates to this page

Published 16 December 2021
Last updated 201 JuneAugust 2025 + show all updates
  1. Updated to remove products from the list. Removed: Avalglucosidase alfa 100mg powder for solution for infusion vials; Dukoral cholera vaccine effervescent powder and suspension for oral suspension - Cholera vaccine (inactivated, oral) effervescent powder and suspension for oral suspension; Cholestagel 625mg tablets - Colesevelam 625mg tablets; Doxylamine 10mg / Pyridoxine 10mg gastro-resistant tablets; Hydroxychloroquine 300mg tablets; Ixiaro vaccine suspension for injection 0.5ml pre-filled syringes - Japanese encephalitis vaccine (inactivated, adsorbed) suspension for injection 0.5ml pre-filled syringes; Neratinib 40mg tablets; Pegasys 135mg/0.5ml solution for injection pre-filled syringes - Peginterferon alfa-2a 135mg/0.5ml solution for injection pre-filled syringes; Pegasys 180mg/0.5ml solution for injection pre-filled syringes - Peginterferon alfa-2a 180mg/0.5ml solution for injection pre-filled syringes; Pegasys 90mg/0.5ml solution for injection pre-filled syringes - Peginterferon alfa-2a 90mg/0.5ml solution for injection pre-filled syringes; Supemtek Quadrivalent vaccine (recombinant) solution for injection 0.5ml pre-filled syringes - Quadrivalent influenza vaccine (recombinant, inactivated) solution for injection 0.5ml pre-filled syringes; Sarilumab 200mg/1.14ml solution for injection pre-filled disposable devices; and Sarilumab 200mg/1.14ml solution for injection pre-filled syringes.

  2. Updated to remove products from the list. Removed: Acetylcysteine 5% eye drops; Alprolix 1,000unit powder and solvent for solution for injection vials - Eftrenonacog alfa 1,000unit powder and solvent for solution for injection vials; Alprolix 2,000unit powder and solvent for solution for injection vials - Eftrenonacog alfa 2,000unit powder and solvent for solution for injection vials; Alprolix 250unit powder and solvent for solution for injection vials - Eftrenonacog alfa 250unit powder and solvent for solution for injection vials; Alprolix 3,000unit powder and solvent for solution for injection vials - Eftrenonacog alfa 3,000unit powder and solvent for solution for injection vials; Alprolix 500unit powder and solvent for solution for injection vials - Eftrenonacog alfa 500unit powder and solvent for solution for injection vials; NovoSeven 2mg (100,000units) powder and solvent for solution for injection pre-filled syringes - Eptacog alfa (activated) 2mg (100,000unit) powder and solvent for solution for injection pre-filled syringes; Glucagon 1mg solution for injection in pre-filled pen; Insulatard penfill 100 units/ml suspension for injection 3 ml cartridges - Insulin Isophane human 100 units/ml suspension for injection 3 ml cartridges; Takhyzro 150 mg solution for injection in pre-filled syringe - Lanadelumab 150 mg solution for injection in pre-filled syringe; Lomustine 40mg capsules; Buccolam 10mg/2ml oromucosal solution pre-filled oral syringes - Midazolam 10mg/2ml oromucosal solution pre-filled oral syringes sugar free; Buccolam 2.5mg/0.5ml oromucosal solution pre-filled oral syringes - Midazolam 2.5mg/0.5ml oromucosal solution pre-filled oral syringes sugar free; Buccolam 5mg/1ml oromucosal solution pre-filled oral syringes - Midazolam 5mg/1ml oromucosal solution pre-filled oral syringes sugar free; Buccolam 7.5mg/1.5ml oromucosal solution pre-filled oral syringes - Midazolam 7.5mg/1.5ml oromucosal solution pre-filled oral syringes sugar free; Omnitrope Pen 5 5mg/1.5ml solution for injection cartridges - Somatropin (rbe) 5mg/1.5ml solution for injection cartridges; and Topotecan 0.25mg capsules.

  3. Updated to add and remove products from the list. Added: Xultophy 100units/ml / 3.6mg/ml solution for injection 3ml pre-filled pens - Insulin degludec 100units/ml / Liraglutide 3.6mg/ml solution for injection 3ml pre-filled disposable devices. Removed: Duaklir 340micrograms/dose / 12micrograms/dose Genuair - Aclidinium bromide 396micrograms/dose / Formoterol 11.8micrograms/dose dry powder inhaler; Amlodipine/Valsartan 5mg/160mg tablets; Atogepant 10mg tablets; Belumosudil 200mg tablets; Cometriq 20mg capsules - Cabozantinib 20mg capsules; Cometriq 20mg capsules and Cometriq 80mg capsules - Cabozantinib 20mg capsules and Cabozantinib 80mg capsules; Cometriq 80mg capsules - Cabozantinib 80mg capsules; Estradiol valerate 2mg / Medroxyprogesterone 5mg tablets; Tresiba FlexTouch 200units/ml solution for injection 3ml pre-filled pens - Insulin degludec 200units/ml solution for injection 3ml pre-filled disposable devices; Lixisenatide 20micrograms/0.2ml solution for injection 3ml pre-filled disposable devices; Panobinostat 10mg capsules; Panobinostat 15mg capsules; Panobinostat 20mg capsules; Rucaparib 200mg tablets; Rucaparib 250mg tablets; Rucaparib 300mg tablets; NutropinAq 10mg/2ml solution for injection cartridges - Somatropin (rbe) 10mg/2ml solution for injection cartridges; Synthamin 14, 8.5% Amino Acid Intravenous Infusion without Electrolytes; Synthamin 17, 10.0% Amino Acid Intravenous Infusion without Electrolytes; and Synthamin 9, 5.5% Amino Acid Intravenous Infusion without Electrolytes.

Sign up for emails or print this page